[TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review].
Bjerrum
Jacob Tveiten
JT
Herlev Hospital, Medicinsk-gastroenterologisk Afdeling C, Region Hovedstadens Sygehus Apotek, Herlev. jacobbjerrum@tiscali.dk.
Munck
Lars Christian
LC
Krogh-Madsen
Mikkel
M
Nielsen
Ole Haagen
OH
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D000069285:Infliximab; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab